Collaborators will be granted a license to fully leverage the Immunome technology, with open rights to use, commercialise and patent discoveries
(PRWeb September 19, 2016)
Read the full story at http://www.prweb.com/releases/2016/09/prweb13690886.htm
For more information, please visit
http://www.prweb.com/releases/2016/09/prweb13690886.htm